On September 12, 2019, Dr. Mauskop spoke on Advances and Controversies in Migraine at Charité – Universitätsmedizin Berlin, Europe’s largest university hospital. In the top photo Dr. Mauskop with Professor Uwe Reuter of Charité and Dr. Zoltan Medgyessy of Detmold Medicum. The middle photo shows the entrance to the renown Psychiatric and Neurologic Clinic at Charité. Bottom photo is of Dr. Mauskop in the lecture hall, where at the top you can see six portraits of physicians, who after 1933 were dismissed and persecuted for political or racial reasons.
You guessed it right, Åsa, the myth of medication overuse headaches (MOH) was one of the topics I discussed at Charité in Berlin. Surprisingly, Prof. Dr. Uwe Reuter, who is the leading headache expert in Germany, agreed that MOH is is uncommon. The majority of headache experts in the US and in Germany as well would also adamantly argue that MOH is common and occurs from triptans, NSAIDs, and other drugs, even though we have no evidence except for caffeine and opioid (narcotic) analgesics.
Your subject ”Advances and Controversies in Migraine” interests me. When I try to spread what I learn from your blog among Swedish migraine sufferers, specifically that MOH from triptans is a myth, some get happy, others get so provoked! Then they all refer to the common knowledge among Swedish migraine doctors, like if they didn’t even read that I wrote that there’s no existing, reliable research that can support this ”common knowledge”.
What’s it like in the US and among migraine specialists around the world?